Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ecotoxicol Environ Saf ; 278: 116427, 2024 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-38733803

RESUMO

BACKGROUND: Neighborhood walkability may influence maternal-fetal exposure to environmental hazards and maternal-fetal health (e.g., fetal growth restriction, reproductive toxicity). However, few studies have explored the association between neighborhood walkability and hormones in pregnant women. METHODS: We included 533 pregnant women from the Hangzhou Birth Cohort Study II (HBCS-II) with testosterone (TTE) and estradiol (E2) measured for analysis. Neighborhood walkability was evaluated by calculating a walkability index based on geo-coded addresses. Placental metals were measured using inductively coupled plasma mass spectrometry (ICP-MS). TTE and E2 levels in umbilical cord blood were measured using chemiluminescence microparticle immunoassay (CMIA). Linear regression model was used to estimate the relationship between the walkability index, placental metals, and sex steroid hormones. Effect modification was also assessed to estimate the effect of placental metals on the associations of neighborhood walkability with TTE and E2. RESULTS: Neighborhood walkability was significantly linked to increased E2 levels (P trend=0.023). Compared with participants at the first quintile (Q1) of walkability index, those at the third quintiles (Q3) had lower chromium (Cr) levels (ß = -0.212, 95% CI = -0.421 to -0.003). Arsenic (As), cobalt (Co), manganese (Mn), molybdenum (Mo), nickel (Ni), lead (Pb), antimony (Sb), selenium (Se), tin (Sn), and vanadium (V) were linked to decreased TTE levels, and cadmium (Cd) was linked to increased TTE levels. No metal was significantly associated with E2 levels in trend analysis. In the analysis of effect modification, the associations of neighborhood walkability with TTE and E2 were significantly modified by Mn (P = 0.005) and Cu (P = 0.049) respectively. CONCLUSION: Neighborhood walkability could be a favorable factor for E2 production during pregnancy, which may be inhibited by maternal exposure to heavy metals.


Assuntos
Características de Residência , Caminhada , Humanos , Feminino , Gravidez , Adulto , China , Estudos de Coortes , Estradiol/sangue , Estradiol/análise , Testosterona/sangue , Sangue Fetal/química , Exposição Materna/estatística & dados numéricos , Poluentes Ambientais/análise , Poluentes Ambientais/sangue , Metais/análise , Metais/sangue , Hormônios Esteroides Gonadais/sangue , Hormônios Esteroides Gonadais/análise , Placenta/química , Placenta/efeitos dos fármacos , Metais Pesados/análise , Adulto Jovem
2.
Eur J Pharmacol ; 965: 176326, 2024 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-38220141

RESUMO

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by cartilage degeneration and subchondral bone remodelling. Currently, conservative treatment strategies cannot effectively alleviate the progression of OA. In this study, we used computer network analysis to show that Nitisinone (NTBC) is closely related to extracellular matrix degradation in OA and mainly interferes with the TNF-α signaling pathway. NTBC is an orphan drug used to treat hereditary type I tyrosinemia by altering phenylalanine/tyrosine metabolic flow. In this study, we found that NTBC effectively reduced chondrocyte inflammation and extracellular matrix degradation induced by TNF-α. Mechanistically, NTBC inhibited the cGAS/STING signaling pathway and reduced activation of the STING-dependent NF-κB pathway to alleviate inflammation. In addition, NTBC inhibited osteoclastogenesis and delayed the occurrence of subchondral bone remodelling. In mice with ACLT-induced osteoarthritis, intra-articular injection of NTBC significantly reduced cartilage degradation and subchondral bone remodelling. NTBC showed impressive therapeutic efficacy as a potential pharmaceutical intervention for the treatment of OA.


Assuntos
Cartilagem Articular , Cicloexanonas , Nitrobenzoatos , Osteoartrite , Camundongos , Animais , NF-kappa B/metabolismo , Osteogênese , Fator de Necrose Tumoral alfa/metabolismo , Osteoartrite/tratamento farmacológico , Osteoartrite/metabolismo , Inflamação/tratamento farmacológico , Condrócitos
3.
FASEB J ; 37(12): e23303, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37983963

RESUMO

Lumbar intervertebral disc degeneration(IDD) is a prevalent inflammatory disease caused by many proinflammatory factors, such as TNF and IL-1ß. Migration inhibitory factor (MIF) is an upstream inflammatory factor widely expressed in vivo that is associated with a variety of inflammatory diseases or malignant tumors and has potential therapeutic value in many diseases. We explored the role of MIF in intervertebral disc degeneration by regulating the content of exogenous MIF or the expression of MIF in cells. Upon inducing degeneration of nucleus pulposus (NP) cells with IL-1ß, we found that the increase in intracellular and exogenous MIF promoted the catabolism induced by proinflammatory factors in NP cells, while silencing of the MIF gene alleviated the degeneration to some extent. In a mouse model, the intervertebral disc degeneration of MIF-KO mice was significantly less than that of wild-type mice. To explore the treatment of intervertebral disc degeneration, we selected the small-molecular MIF inhibitor CPSI-1306. CPSI-1306 had a therapeutic effect on intervertebral disc degeneration in the mouse model. In summary, we believe that MIF plays an important role in intervertebral disc degeneration and is a potential therapeutic target for the treatment of intervertebral disc degeneration.


Assuntos
Degeneração do Disco Intervertebral , Disco Intervertebral , Fatores Inibidores da Migração de Macrófagos , Núcleo Pulposo , Camundongos , Animais , NF-kappa B/metabolismo , Degeneração do Disco Intervertebral/metabolismo , Transdução de Sinais/fisiologia , Fatores Inibidores da Migração de Macrófagos/metabolismo , Núcleo Pulposo/metabolismo , Disco Intervertebral/metabolismo
4.
Biomed Res Int ; 2018: 3429569, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30515393

RESUMO

OBJECTIVES: To purify and characterize the glutathione binding protein GsiB of glutathione importer (GSI) in Escherichia coli (E. coli). RESULTS: The coding sequence of GsiB was cloned from E. coli MG1655 and expressed in BL21(DE3). GsiB protein was expressed and purified to homogeneity using Ni-affinity and gel filtration chromatography. SDS-PAGE of purified GsiB showed a single protein band of molecular mass 56 kDa, while native gel showed two bands around 56 kDa and 110 kDa. Gene knockout showed that GsiB was essential for GSI mediated glutathione import. Interactions of GsiA, B, C, and D were determined using bacterial two-hybrid method. Without glutathione, GsiB showed no direct interaction with the other three proteins. However, GsiB could interact with GsiC and GsiD when using glutathione as sole sulfur source. CONCLUSIONS: GsiB functions in E. coli was characterized which could help elucidate the glutathione import mechanism in gram-negative bacteria.


Assuntos
Proteínas de Escherichia coli/isolamento & purificação , Escherichia coli/genética , Glutationa/química , Proteínas de Membrana Transportadoras/isolamento & purificação , Cromatografia em Gel , Clonagem Molecular , Eletroforese em Gel de Poliacrilamida , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica/genética , Glutationa/genética , Proteínas de Membrana Transportadoras/química , Proteínas de Membrana Transportadoras/genética , Ligação Proteica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA